Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Hypoadiponectinemia and proinflammatory state: two sides of the same coin?: results from the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4).

    Herder C, Hauner H, Haastert B, Röhrig K, Koenig W, Kolb H, Müller-Scholze S, Thorand B, Holle R, Rathmann W.

    Diabetes Care. 2006 Jul;29(7):1626-31.PMID: 16801589 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).

    Herder C, Haastert B, Müller-Scholze S, Koenig W, Thorand B, Holle R, Wichmann HE, Scherbaum WA, Martin S, Kolb H.

    Diabetes. 2005 Dec;54 Suppl 2:S11-7.PMID: 16306328 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).

    Herder C, Kolb H, Koenig W, Haastert B, Müller-Scholze S, Rathmann W, Holle R, Thorand B, Wichmann HE.

    Diabetes Care. 2006 Feb;29(2):368-71.PMID: 16443889 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Inflammation and type 2 diabetes: results from KORA Augsburg.

    Herder C, Illig T, Rathmann W, Martin S, Haastert B, Müller-Scholze S, Holle R, Thorand B, Koenig W, Wichmann HE, Kolb H; KORA Study Group.

    Gesundheitswesen. 2005 Aug;67 Suppl 1:S115-21.PMID: 16032528 [PubMed - indexed for MEDLINE]Related articles

    5.

    Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia.

    Schinner S, Kempf K, Overmann H, Willenberg HS, Schott M, Rose B, Scherbaum WA, Herder C.

    Exp Clin Endocrinol Diabetes. 2008 Sep;116 Suppl 1:S64-9. Epub 2008 Sep 5.PMID: 18777458 [PubMed - indexed for MEDLINE]Related articles

    6.

    Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome.

    Winer JC, Zern TL, Taksali SE, Dziura J, Cali AM, Wollschlager M, Seyal AA, Weiss R, Burgert TS, Caprio S.

    J Clin Endocrinol Metab. 2006 Nov;91(11):4415-23. Epub 2006 Aug 22.PMID: 16926246 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).

    Herder C, Müller-Scholze S, Rating P, Koenig W, Thorand B, Haastert B, Holle R, Illig T, Rathmann W, Seissler J, Wichmann HE, Kolb H.

    Eur J Endocrinol. 2006 Feb;154(2):311-7.PMID: 16452546 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.

    Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, Illig T, Martin S, Kolb H.

    Diabetologia. 2006 May;49(5):921-9. Epub 2006 Mar 11.PMID: 16532324 [PubMed - indexed for MEDLINE]Related articles

    9.

    Low-grade inflammation, obesity, and insulin resistance in adolescents.

    Herder C, Schneitler S, Rathmann W, Haastert B, Schneitler H, Winkler H, Bredahl R, Hahnloser E, Martin S.

    J Clin Endocrinol Metab. 2007 Dec;92(12):4569-74. Epub 2007 Oct 2.PMID: 17911172 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

    Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM.

    Diabetes Care. 2006 Nov;29(11):2498-503.PMID: 17065691 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

    Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, Herder C.

    Diabetes Care. 2007 Apr;30(4):854-60.PMID: 17392546 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Adiponectin independently predicts metabolic syndrome in overweight Latino youth.

    Shaibi GQ, Cruz ML, Weigensberg MJ, Toledo-Corral CM, Lane CJ, Kelly LA, Davis JN, Koebnick C, Ventura EE, Roberts CK, Goran MI.

    J Clin Endocrinol Metab. 2007 May;92(5):1809-13. Epub 2007 Feb 20.PMID: 17311859 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes.

    Fukui M, Ose H, Kitagawa Y, Kamiuchi K, Nakayama I, Ohta M, Obayashi H, Yamasaki M, Hasegawa G, Yoshikawa T, Nakamura N.

    Diabet Med. 2007 Aug;24(8):864-71. Epub 2007 Jun 25.PMID: 17593243 [PubMed - indexed for MEDLINE]Related articles

    15.

    Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.

    Pfleger C, Mortensen HB, Hansen L, Herder C, Roep BO, Hoey H, Aanstoot HJ, Kocova M, Schloot NC; Hvidøre Study Group on Childhood Diabetes.

    Diabetes. 2008 Apr;57(4):929-37. Epub 2008 Feb 25.PMID: 18299313 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes.

    Illig T, Bongardt F, Schöpfer A, Müller-Scholze S, Rathmann W, Koenig W, Thorand B, Vollmert C, Holle R, Kolb H, Herder C; Kooperative Gesundheitsforschung im Raum Augsburg/Cooperative Research in the Region of Augsburg.

    J Clin Endocrinol Metab. 2004 Oct;89(10):5053-8. Erratum in: J Clin Endocrinol Metab. 2005 Dec;90(12):6385. PMID: 15472205 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes.

    Comuzzie AG, Tejero ME, Funahashi T, Martin LJ, Kissebah A, Takahashi M, Kihara S, Tanaka S, Rainwater DL, Matsuzawa Y, MacCluer JW, Blangero J.

    Hum Biol. 2007 Apr;79(2):191-200.PMID: 18027814 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter.

    Schwarz PE, Towers GW, Fischer S, Govindarajalu S, Schulze J, Bornstein SR, Hanefeld M, Vasseur F.

    Diabetes Care. 2006 Jul;29(7):1645-50.PMID: 16801592 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Interleukin-10 associates with adiponectin predominantly in subjects with metabolic syndrome.

    Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K.

    Circ J. 2007 Aug;71(8):1234-8.PMID: 17652887 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes.

    Yaturu S, Daberry RP, Rains J, Jain S.

    Cytokine. 2006 May;34(3-4):219-23. Epub 2006 Jul 5.PMID: 16822679 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data